Login
$KARD
$12.85 +$0.00 (0.0%) After hours

$KARD SEC Filings

Filed On Filing
12 Nov 2026 10-Q
12 Nov 2026 8-K: Results of Operations and Financial Condition

Completed enrollment in Cohort 2 of Phase 2b danicamtiv KINSHIP-DCM trial, topline data expected in 2Q 2027; Phase 3 enrollment underway in both cohorts

06 Nov 2026 8-K: Regulation FD Disclosure

Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial and Announces New Evidence Supporting Patient Selection and Endpoints for the Evaluation of Ataciguat in Aortic Stenosis

01 Oct 2026 Form 4: Reinke Kristin Marie K, Director

Granted 48,368 Stock Options (right to buy)

01 Oct 2026 Form 3: Reinke Kristin Marie K, Director

No securities owned

01 Oct 2026 SCHEDULE 13D/A
30 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

SOUTH SAN FRANCISCO, Calif., and PRINCETON, N.J., September 30, 2026 — Kardigan™, Inc. (Nasdaq: KARD) (“Kardigan”), a precision cardiovascular company, announced today the appointment of Kristin Reinke to its Board of Directors, where sh...

13 Aug 2026 SCHEDULE 13G
13 Aug 2026 SCHEDULE 13G
11 Aug 2026 10-Q
11 Aug 2026 8-K: Results of Operations and Financial Condition

Continued to advance the development of three late-stage programs, supported by the Prolaio platform, aimed at addressing cardiovascular diseases where no approved treatments exist

07 Aug 2026 SCHEDULE 13G/A
06 Aug 2026 SCHEDULE 13G
13 Jul 2026 Form 4: Perceptive Advisors Llc, Director and 3 others

Received 20,706 shares as a grant or award

29 Jun 2026 SCHEDULE 13G
29 Jun 2026 SCHEDULE 13D
25 Jun 2026 SCHEDULE 13D
24 Jun 2026 Form 4: Hrtg GPE, Llc, 10% owner and 4 others

Bought 3,125,000 shares ($50M)

24 Jun 2026 Form 3/A: Hrtg GPE, Llc, 10% owner and 4 others
24 Jun 2026 Form 4: Berns Paul L, Director

Bought 1,250,000 shares ($20M)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support